KMDA(Kamada Ltd.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $103.64M | $129.34M | $142.52M | $160.95M | $180.46M |
| 毛利润 | $30.33M | $46.70M | $55.49M | $69.97M | $76.41M |
| 营业利润 | −$696.00K | $4.53M | $10.06M | $20.05M | $26.23M |
| 净利润 | −$2.23M | −$2.32M | $8.28M | $14.46M | $20.20M |
| 经营现金流 | −$8.82M | $28.59M | $4.32M | $47.59M | $25.49M |
| 自由现金流 | −$12.55M | $24.80M | −$1.53M | $36.85M | $15.64M |
| 摊薄每股收益 | $-0.05 | $-0.05 | $0.15 | $0.25 | $0.35 |